ORIGINAL REPORTS
Pediatric Oncology
- Phase II Window Study on Rituximab in Newly Diagnosed Pediatric Mature B-Cell Non-Hodgkin's Lymphoma and Burkitt Leukemia
Andrea Meinhardt, Birgit Burkhardt, Martin Zimmermann, Arndt Borkhardt, Udo Kontny, Thomas Klingebiel, Frank Berthold, Gritta Janka-Schaub, Christoph Klein, Edita Kabickova, Wolfram Klapper, Andishe Attarbaschi, Martin Schrappe, and Alfred Reiter
JCO Jul 2010: 3115–3121. First published on Jun 1 2010; 10.1200/JCO.2009.26.6791.
Thoracic Oncology
- Phase II Proof-of-Concept Study of Pazopanib Monotherapy in Treatment-Naive Patients With Stage I/II Resectable Non–Small-Cell Lung Cancer
Nasser Altorki, Maureen E. Lane, Thomas Bauer, Paul C. Lee, Michael J. Guarino, Harvey Pass, Enriqueta Felip, Nili Peylan-Ramu, Alfonso Gurpide, Frederic W. Grannis, John D. Mitchell, Sabrina Tachdjian, R. Suzanne Swann, Anne Huff, Debasish F. Roychowdhury, Anthony Reeves, Lone H. Ottesen, and David F. Yankelevitz
JCO Jul 2010: 3131–3137. First published on Jun 1 2010; 10.1200/JCO.2009.23.9749.
- Preoperative Chemotherapy Plus Surgery Versus Surgery Plus Adjuvant Chemotherapy Versus Surgery Alone in Early-Stage Non–Small-Cell Lung Cancer
Enriqueta Felip, Rafael Rosell, José Antonio Maestre, José Manuel Rodríguez-Paniagua, Teresa Morán, Julio Astudillo, Guillermo Alonso, José Manuel Borro, José Luis González-Larriba, Antonio Torres, Carlos Camps, Ricardo Guijarro, Dolores Isla, Rafael Aguiló, Vicente Alberola, José Padilla, Abel Sánchez-Palencia, José Javier Sánchez, Eduardo Hermosilla, and Bartomeu Massuti
JCO Jul 2010: 3138–3145. First published on Jun 1 2010; 10.1200/JCO.2009.27.6204.
Hematologic Malignancies
- Phase III Study of the Value of Thalidomide Added to Melphalan Plus Prednisone in Elderly Patients With Newly Diagnosed Multiple Myeloma: The HOVON 49 Study
Pierre Wijermans, Martijn Schaafsma, Fabian Termorshuizen, Rianne Ammerlaan, Shulamiet Wittebol, Harm Sinnige, Sonja Zweegman, Marinus van Marwijk Kooy, René van der Griend, Henk Lokhorst, and Pieter Sonneveld
JCO Jul 2010: 3160–3166. First published on Jun 1 2010; 10.1200/JCO.2009.26.1610.
Breast Cancer
- Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
David W. Miles, Arlene Chan, Luc Y. Dirix, Javier Cortés, Xavier Pivot, Piotr Tomczak, Thierry Delozier, Joo Hyuk Sohn, Louise Provencher, Fabio Puglisi, Nadia Harbeck, Guenther G. Steger, Andreas Schneeweiss, Andrew M. Wardley, Andreas Chlistalla, and Gilles Romieu
JCO Jul 2010: 3239–3247. First published on May 24 2010; 10.1200/JCO.2008.21.6457.
- Phase II Study to Evaluate the Efficacy and Safety of Neoadjuvant Lapatinib Plus Paclitaxel in Patients With Inflammatory Breast Cancer
Hamouda Boussen, Massimo Cristofanilli, Tal Zaks, Michelle DeSilvio, Vanessa Salazar, and Neil Spector
JCO Jul 2010: 3248–3255. First published on Jun 7 2010; 10.1200/JCO.2009.21.8594.
- Randomized Phase III Trial of Ixabepilone Plus Capecitabine Versus Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
Joseph A. Sparano, Eduard Vrdoljak, Oliver Rixe, Binghe Xu, Alexey Manikhas, Carlos Medina, Susanne Crocamo Ventilari Da Costa, Jungsil Ro, Gonzalo Rubio, Monica Rondinon, Gumersindo Perez Manga, Ronald Peck, Valerie Poulart, and Pierfranco Conte
JCO Jul 2010: 3256–3263. First published on Jun 7 2010; 10.1200/JCO.2009.24.4244.
Palliative and Supportive Care
- Phase III, Placebo-Controlled Trial of Three Doses of Citalopram for the Treatment of Hot Flashes: NCCTG Trial N05C9
Debra L. Barton, Beth I. LaVasseur, Jeff A. Sloan, Allen N. Stawis, Kathleen A. Flynn, Missy Dyar, David B. Johnson, Pamela J. Atherton, Brent Diekmann, and Charles L. Loprinzi
JCO Jul 2010: 3278–3283. First published on May 24 2010; 10.1200/JCO.2009.26.6379.
Thoracic Oncology
- Phase III Trial Comparing Docetaxel and Cisplatin Combination Chemotherapy With Mitomycin, Vindesine, and Cisplatin Combination Chemotherapy With Concurrent Thoracic Radiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: OLCSG 0007
Yoshihiko Segawa, Katsuyuki Kiura, Nagio Takigawa, Haruhito Kamei, Shingo Harita, Shunkichi Hiraki, Yoichi Watanabe, Keisuke Sugimoto, Takuo Shibayama, Toshiro Yonei, Hiroshi Ueoka, Mitsuhiro Takemoto, Susumu Kanazawa, Ichiro Takata, Naoyuki Nogami, Katsuyuki Hotta, Akio Hiraki, Masahiro Tabata, Keitaro Matsuo, and Mitsune Tanimoto
JCO Jul 2010: 3299–3306. First published on Jun 7 2010; 10.1200/JCO.2009.24.7577.
Head and Neck Cancer
Thoracic Oncology
- Randomized Phase II Trial of All-Trans-Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-Line Treatment in Patients With Advanced Non–Small-Cell Lung Cancer
Oscar Arrieta, Claudia H. González-De la Rosa, Elena Aréchaga-Ocampo, Geraldine Villanueva-Rodríguez, Tania L. Cerón-Lizárraga, Luis Martínez-Barrera, María E. Vázquez-Manríquez, Miguel Ángel Ríos-Trejo, Miguel Á. Álvarez-Avitia, Norma Hernández-Pedro, Carlos Rojas-Marín, and Jaime De la Garza
JCO Jul 2010: 3463–3471. First published on Jun 14 2010; 10.1200/JCO.2009.26.6452.
Gastrointestinal Cancer
- Phase II Study of the Anti-Cytotoxic T-Lymphocyte–Associated Antigen 4 Monoclonal Antibody, Tremelimumab, in Patients With Refractory Metastatic Colorectal Cancer
Ki Y. Chung, Ira Gore, Lawrence Fong, Alan Venook, Stephen B. Beck, Prudence Dorazio, Peggy J. Criscitiello, Diane I. Healey, Bo Huang, Jesus Gomez-Navarro, and Leonard B. Saltz
JCO Jul 2010: 3485–3490. First published on May 24 2010; 10.1200/JCO.2010.28.3994.
- Report of a Multicenter Phase II Trial Testing a Combination of Biweekly Bevacizumab and Daily Erlotinib in Patients With Unresectable Biliary Cancer: A Phase II Consortium Study
Sam J. Lubner, Michelle R. Mahoney, Jill L. Kolesar, Noelle K. LoConte, George P. Kim, Henry C. Pitot, Philip A. Philip, Joel Picus, Wei-Peng Yong, Lisa Horvath, Guy Van Hazel, Charles E. Erlichman, and Kyle D. Holen
JCO Jul 2010: 3491–3497. First published on Jun 7 2010; 10.1200/JCO.2010.28.4075.
ASCO SPECIAL ARTICLE
- American Society of Clinical Oncology Provisional Clinical Opinion: Chronic Hepatitis B Virus Infection Screening in Patients Receiving Cytotoxic Chemotherapy for Treatment of Malignant Diseases
Andrew S. Artz, Mark R. Somerfield, Jordan J. Feld, Andrew F. Giusti, Barnett S. Kramer, Anita L. Sabichi, Robin T. Zon, and Sandra L. Wong
JCO Jul 2010: 3199–3202. First published on Jun 1 2010; 10.1200/JCO.2010.30.0673.
- American Society of Clinical Oncology Clinical Practice Guideline on Uses of Serum Tumor Markers in Adult Males With Germ Cell Tumors
Timothy D. Gilligan, Jerome Seidenfeld, Ethan M. Basch, Lawrence H. Einhorn, Timothy Fancher, David C. Smith, Andrew J. Stephenson, David J. Vaughn, Roxanne Cosby, and Daniel F. Hayes
JCO Jul 2010: 3388–3404. First published on Jun 7 2010; 10.1200/JCO.2009.26.4481.
REVIEW ARTICLE
